Sab Biotherapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.90

+0.05 (+1.30%)

As of Aug 15, 2:10 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +705.4% upside

Low Target $26.29

Average Target $31.41

High Target $48.84

Current Price $3.90

Current
$3.90

Target
$31.41

$26.29 $31.41 avg $48.84

Scenario Analysis

Bear Case

$26.29

574.1%

Low target

Base Case

$31.41

+705.4%

Avg target

Bull Case

$48.84

+1,152.3%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$5.15

-24.3% from high

52-Week Low

$1.85

+110.8% from low

Target vs 52W High

$31.41

+509.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%